Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
Outline of Final Research Achievements |
We studied the influence of Siglec pathway on airway remodeling, which is a refractory factor of bronchial asthma. Siglec is a sugar chain-binding protein mainly expressed in inflammatory cells, mouse Siglec-F is mainly expressed on eosinophils. Muc 5b and Muc 4 were identified as ligands for Siglec-F. In addition, the expression level of Siglec-F ligand was increased when airway remodeling was progressed. Hyaluronan synthase HAS2 dysfunction seemed to inhibit the Siglec pathway and may induce refractory asthma.
|